ABSTRACT
The past two decades have witnessed a proliferation of commercially available molecular assays for commonly-encountered human parasites.1,2 Some assays are authorized for in vitro diagnostic use by national accrediting bodies, whereas many more are available as non-authorized kits that must be thoroughly evaluated by the clinical laboratory prior to clinical use. Likewise, some assays are available in convenient, easy-to-use, cartridge based formats, while others are available as individual reagents that must be assembled for use in the laboratory. This session will discuss the range of currently available commercial molecular assays and discuss their pros and cons. References 1. Ryan U, Paparini A, Oskam C. New technologies for detection of enteric parasites. Trends Parasitol 2017;33: 532-546. 2. Chandra Parija S, Poddar A. Molecular diagnosis of infectious parasites in the post-COVID-19 era. Trop Parasitol 2021;11: 3-10. Copyright © 2021